Clinical Trials Sponsored by Bial Foundation

Total 15870 results

Novavax
Bill and Melinda Gates Foundation

Completed

A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

COVID-19 | SARS-CoV-2 Infection

South Africa
Jhpiego
Bill and Melinda Gates Foundation

Completed

Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach

Stillbirth | Neonatal Death
IDRI
Bill and Melinda Gates Foundation

Completed

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
Jhpiego
Bill and Melinda Gates Foundation

Completed

Effects of a Health Workforce Capacity Building and Quality Improvement Intervention in Kinshasa

Infant Death | Maternal Death | Stillbirth

Congo, The Democratic Republic of the
Novavax
Bill and Melinda Gates Foundation

Completed

A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization

Respiratory Syncytial Virus Infections

United States, Argentina, Australia, Bangladesh, Chile, Mexico, New Zealand, Philippines, South Africa, Spain, United Kingdom
IDRI
Bill and Melinda Gates Foundation

Completed

Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers

Visceral Leishmaniasis

United States
IDRI
Bill and Melinda Gates Foundation

Completed

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Visceral Leishmaniasis | Post-kala-azar Dermal Leishmaniasis

India
PATH
Bill and Melinda Gates Foundation

Withdrawn

Efficacy of iOWH032 in Dehydrating Cholera (POC)

Secretory Diarrhea

Bangladesh
PATH
Bill and Melinda Gates Foundation

Completed

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

Virus Diseases | Hepatitis B
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Leishmaniasis, Mucocutaneous

Peru
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Leishmaniasis, Cutaneous

Brazil
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
Ataulpho de Paiva Foundation
Bill and Melinda Gates Foundation

Completed

Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil

Tuberculosis

Brazil
University of Liege
Centre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...

Recruiting

Cognitive Trance, Hypnosis and Meditation in Oncology

Pain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, Emotional

Belgium
Population Council
Bill and Melinda Gates Foundation

Recruiting

Pilot Study on Engaging Family Physicians in Family Planning in Pakistan (FPFP)

Contraception | Contraceptive Usage

Pakistan
FHI 360
Bill and Melinda Gates Foundation

Recruiting

Casea S Contraceptive Implants (Casea S) Trial

Contraception

Dominican Republic
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV

Poliomyelitis

Dominican Republic, Panama
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age (T2-ABMG)

Poliomyelitis
Fidec Corporation
Bill and Melinda Gates Foundation

Withdrawn

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

Poliomyelitis
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania (M3-ABMG)

Poliomyelitis
FHI 360
Bill and Melinda Gates Foundation

Completed

Safety,Effectiveness and Acceptability of Sino-implant II in DR

Contraception

Dominican Republic
Boston University
Bill and Melinda Gates Foundation

Completed

Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia

Pneumonia, Bacterial | Infections, Bacterial

Malawi
Vaxtrials S.A.
Bill and Melinda Gates Foundation

Completed

Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life (IPV005)

Polio

Panama
Artann Laboratories
Bill and Melinda Gates Foundation

Completed

Clinical Evaluation of Ultrasonic Hydration Monitor for Infants (IHM-01)

Diarrhea | Dehydration

Latvia
Elizabeth Glaser Pediatric AIDS Foundation
Bill and Melinda Gates Foundation

Active, not recruiting

Evaluation of Advanced HIV Disease Differentiated Care Model in Malawi

AIDS-related Kaposi Sarcoma | Cryptococcal Infections | AIDS and Infections | Opportunistic Infections, HIV-Related | AIDS With Tuberculosis

Malawi
Fidec Corporation
Bill and Melinda Gates Foundation

Active, not recruiting

A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2

Poliomyelitis

Bangladesh
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine

Poliomyelitis

Panama
Stanford University
Bill and Melinda Gates Foundation

Completed

Team-Based Goals and Incentives for Community-Based Health Workers to Promote Maternal and Child Health in Bihar, India

Healthy
Certara
Bill and Melinda Gates Foundation; Parexel

Completed

International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global) (UNITY Global)

Covid19 | SARS-CoV Infection

Pakistan
Makerere University
Bill and Melinda Gates Foundation

Active, not recruiting

Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage

Polio

Uganda
Fidec Corporation
Bill and Melinda Gates Foundation

Withdrawn

A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine

Poliomyelitis
FHI 360
Bill and Melinda Gates Foundation

Completed

Contraceptive Effectiveness of Sino-implant (II) in China

Contraception

China
PATH
Bill and Melinda Gates Foundation; UNITAID

Recruiting

TIMCIs: A Hybrid Type 2 Study of Next-generation Pulse Oximeters

Focus of Study: Accurate Clinical Measurement and Diagnosis

Kenya
Tufts University
Bill and Melinda Gates Foundation

Recruiting

Safe and Effective Delivery of Supplemental Iron to Healthy Volunteers

Iron

United States
Yale University
Bill and Melinda Gates Foundation

Completed

Topical Antibacterial Agents for Prevention of COVID-19

COVID-19 | SARS-CoV2 Infection

United States
Stanford University
Bill and Melinda Gates Foundation

Completed

Use of Mobile Technology by Community-Based Health Workers to Promote Maternal and Child Health in Bihar, India (ICT-CCS)

Child | Pregnancy | Infant | Nutrition | Health
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants

Poliomyelitis

Dominican Republic
Fidec Corporation
Bill and Melinda Gates Foundation

Completed

A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children (M2-ABMG)

Adverse Event Following Immunisation
VaxInnate Corporation
Bill and Melinda Gates Foundation

Completed

Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults

Influenza Infection

United States
Makerere University
Bill and Melinda Gates Foundation

Completed

School Based Malaria Control in Ugandan Schoolchildren (SBMC)

Malaria

Uganda
Bial - Portela C S.A.

Active, not recruiting

OpicApone Sleep dISorder (OASIS)

Parkinson Disease

Portugal
Bial - Portela C S.A.

Terminated

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

Pulmonary Arterial Hypertension
Bial - Portela C S.A.

Completed

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058 (ADME)

Pulmonary Arterial Hypertension

Netherlands
Bial - Portela C S.A.

Completed

Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)

Parkinson Disease

United Kingdom
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children

Partial Epilepsy in Children and Adolescents

United Kingdom, Spain, Serbia, Italy, Austria, Bosnia and Herzegovina, Croatia, Czechia, France, Germany, Hungary, Malaysia, Moldova, Republic of, Philippines, Poland, Portugal, Romania, Russian Federation, Slovakia, Taiwan, Ukr...
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures

Epilepsy
Bial - Portela C S.A.

Completed

Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Healthy

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

Epilepsy

Portugal

Clinical Trials Sponsored by Bial Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations